Clinical Trials in Colorado

Showing 5821-5840 of 18,143 trials

Single-Session Intervention Targeting Self-Injurious Behavior in Adolescents

NCT04498143

Participants (aged 13-16) will be randomized to: (1) an online, active control group program encouraging feelings disclosure (i.e. supportive therapy single session intervention \[SSI\]), or (2) an online program targeting nonsuicidal self-injury (NSSI; i.e. Project "SAVE"-Stop Adolescent Violence Everywhere-SSI). Investigators will test whether SAVE results in significantly greater: 1. Reductions in NSSI 3 months post-treatment \[primary outcome\] 2. Reductions in self-reported likelihood of future NSSI immediately post-treatment \[secondary outcome\] 3. Reduction in suicide ideation frequency 3 months post-treatment \[secondary outcome\]

Nonsuicidal Self InjurySelf HatredSuicidal Thoughts+1 more

University of Denver565 participantsStarted Aug 2020

Denver, Colorado, United States

COMPLETEDPhase 353 miles

Isavuconazole in the Treatment of Renally Impaired Aspergillosis and Rare Fungi

NCT00634049

The purpose of this study is to investigate the efficacy and safety of isavuconazole in the treatment of renally impaired participants with invasive fungal infections caused by Aspergillus and participants with invasive fungal disease caused by rare fungi.

AspergillosisInvasive Fungal Infections

Astellas Pharma Inc149 participantsStarted Apr 2008

Birmingham, Alabama, United States • Duarte, California, United States • Sacramento, California, United States +93 more locations

Single-Session Intervention Targeting Self-Injurious Behavior in Adolescents

Isavuconazole in the Treatment of Renally Impaired Aspergillosis and Rare Fungi

Find Trials by Condition in Colorado

Effects of DHEA and Exercise on Bone Marrow Fat in Postmenopausal Women

Assessment of Safety of the Use of Fenfluramine in Children With Dravet Syndrome Under 24 Months of Age

Narrative Intervention for Long COVID-19 (NICO)

Using Simplified Meal Boluses Versus Carbohydrate Counting in Adolescents With Hybrid Closed Loop Systems

Pragmatic Trial Examining Oxygenation Prior to Intubation

A Study of ASP8273 vs. Erlotinib or Gefitinib in First-line Treatment of Patients With Stage IIIB/IV Non-small Cell Lung Cancer Tumors With EGFR Activating Mutations

De-Implementation of Unnecessary Surgical Antibiotic Prophylaxis in Children

SpineJack System Postmarket Registry

realMIND: Observational Study on Safety and Effectiveness of Tafasitamab in Combination With Lenalidomide in Patients With Relapsed or Refractory DLBCL

Efficacy and Safety of MK-1942 as an Adjunct Therapy in Participants With Mild to Moderate Alzheimer's Disease Dementia (MK-1942-008)

A Phase III Trial of e-TNS for the Acute Treatment of Migraine

Study of PULSAR-ICI +/- IMSA101 in Patients with Oligoprogressive Solid Tumor Malignancies

Phase 1b, Open-Label Study to Evaluate the Safety, Tolerability, and Pharmacodynamics of EP262 in Subjects With Chronic Inducible Urticaria

A Phase 3 Open-Label Study of Eculizumab in Pediatric Participants With Refractory Generalized Myasthenia Gravis (gMG)

Study Evaluating the Efficacy and Safety of OCS-01 Eye Drops in Subjects Following Cataract Surgery

A Study of Bispecific Antibody MCLA-145 in Patients With Advanced or Metastatic Malignancies

A Long Term Extension Study to Assess the Safety of TB006 in Participants With Alzheimer's Disease

An Open-Label Study of Oral NNZ-2591 in Prader-Willi Syndrome (PWS-001)